Morgan Stanley Put 300 AMGN 18.12.../ DE000MJ3Q4M6 /
03/01/2025 17:53:21 | Diferencia-0.02 | Bid22:00:40 | Ask22:00:40 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
6.20EUR | -0.32% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
Amgen Inc | 300.00 USD | 18/12/2026 | Put |
GlobeNewswire
29/08/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
28/08/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
15/08/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
12/08/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08/08/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/08/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
05/08/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
01/08/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página